Cost-effectiveness of shared decision-making in determining challenge setting for nonsevere food protein-induced enterocolitis syndrome
- 15 March 2025
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 134 (6) , 706-712.e2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic ReviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2023
- The evolution of food protein–induced enterocolitis syndromeAnnals of Allergy, Asthma & Immunology, 2021
- Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergyAnnals of Allergy, Asthma & Immunology, 2020
- The cost-effectiveness of requiring universal vs contextual self-injectable epinephrine autoinjector for allergen immunotherapyAnnals of Allergy, Asthma & Immunology, 2019
- Providing cost-effective care for food allergyAnnals of Allergy, Asthma & Immunology, 2019
- A primer on cost-effectiveness in the allergy clinicAnnals of Allergy, Asthma & Immunology, 2019
- Food Protein–Induced Enterocolitis Syndrome Food Challenges: Experience from a Large Referral CenterThe Journal of Allergy and Clinical Immunology: In Practice, 2019
- An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxisAnnals of Allergy, Asthma & Immunology, 2019
- International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & ImmunologyJournal of Allergy and Clinical Immunology, 2017
- Traveling Towards Disease: Transportation Barriers to Health Care AccessJournal of Community Health, 2013